|
|
30.05.25 - 18:45
|
XFRA: 22W0: Wiederaufnahme/Resumption (XETRA)
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
WELLNEX LIFE LTD O.N. 22W0 AU0000162281
AB/FROM ONWARDS 30.05.2025 18:37 CET...
|
|
27.05.25 - 08:54
|
XFRA: 22W0: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
WELLNEX LIFE LTD O.N. 22W0 AU0000162281 BAW/UFN...
|
|
|
|
|
20.03.25 - 07:57
|
XFRA : 22W0: Wiederaufnahme/Resumption (XETRA)
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
WELLNEX LIFE LTD O.N. 22W0 AU0000162281
AB/FROM ONWARDS 20.03.2025...
|
|
18.03.25 - 08:24
|
XFRA : 22W0: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
WELLNEX LIFE LTD O.N. 22W0 AU0000162281 BAW/UFN...
|
|
|
|
21.02.25 - 02:24
|
Wellnex Life directors commit $1.5m to current entitlement offer (Small Caps)
|
|
The directors of diverse consumer healthcare business Wellnex Life (ASX: WNX) have committed to subscribe for a minimum of $1.5 million as part of the company's current entitlement offer. The offer is part of the company's growth strategy, which includes a proposed listing on the AIM market of the London Stock Exchange. Funds raised and […]
The post Wellnex Life directors commit $1.5m to current entitlement offer appeared first on Small Caps....
|
|
20.02.25 - 01:01
|
Wellnex Life secures $14.3m for dual listing on London Stock Exchange (Small Caps)
|
|
Wellnex Life (ASX: WNX) has secured conditional binding commitments to raise $14.3 million to fund its proposed dual listing on the London Stock Exchange's (LSE) Alternative Investment Market (AIM) next month. The company has received interest from UK and Australian institutions and sophisticated investors for a non-renounceable pro-rata entitlement offer of one new Wellnex share […]
The post Wellnex Life secures $14.3m for dual listing on London Stock Exchange appeared first on Small Caps....
|
|
14.02.25 - 08:09
|
XFRA : 22W0: Wiederaufnahme/Resumption (XETRA)
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
WELLNEX LIFE LTD O.N. 22W0 AU0000162281
AB/FROM ONWARDS 14.02.2025...
|
|
14.02.25 - 05:01
|
Wellnex Life raises $9m ahead of proposed London Stock Exchange AIM listing (Small Caps)
|
|
Healthcare business Wellnex Life (ASX: WNX) has received initial conditional binding commitments of $9 million to support its proposed dual listing on the AIM sub-market of the London Stock Exchange (LSE). After receiving significant interest from UK-based institutions and sophisticated investors, the company launched the 1:1 non-renounceable entitlement offer it had previously announced earlier this […]
The post Wellnex Life raises $9m ahead of proposed London Stock Exchange AIM listing appeared first on Small Caps....
|
|
12.02.25 - 07:48
|
XFRA : 22W0: Aussetzung/Suspension (XETRA)
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
WELLNEX LIFE LTD O.N. 22W0 AU0000162281 BAW/UFN...
|
|
|
|
04.02.25 - 04:24
|
Wellnex Life expands global reach with UK market entry and new product approval (Small Caps)
|
|
Wellnex Life (ASX: WNX) has achieved another breakthrough in its expansion plans with a new market authorisation (MA) for its liquid paracetamol plus caffeine soft gel. The MA comes after Wellnex made a successful submission to Australia's Therapeutic Goods Administration for the latest addition to its product range. The company had previously been granted MAs […]
The post Wellnex Life expands global reach with UK market entry and new product approval appeared first on Small Caps....
|
|
|
03.02.25 - 02:48
|
Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE (Small Caps)
|
|
Wellnex Life (ASX: WNX) has reported record sales of $3 million per month for November and December 2024, with 56% of the revenue coming from its own high-margin brands. The total of $11.94m in sales for the first half of the financial year 2025 represented an increase of 112% against the $5.63m recorded in the previous […]
The post Wellnex Life reports record $3m in monthly sales as it pursues dual listing on LSE appeared first on Small Caps....
|
|